Leucoaraiosis y su relación con los niveles de homocisteína en los pacientes con demencia
Contenido principal del artículo
Resumen
La deficiencia total o funcional de vitamina B12 se ha relacionado con la presencia de lesiones a pequeño vaso cerebral, conocido radiológicamente como leucoaraiosis.
Detalles del artículo
Sección
Cómo citar
Referencias
González JA, González MC, Flórez-Tascón FJ, et al. Demencia Alzheimer: patogenia. Geriátrica 2003; 19(Supl. 1): 18-26.
López-Pousa S, Garré-Olmo J, Turón-Estrada A, et al. De los costes de la enfermedad de Alzheimer en función del deterioro cognitivo y funcional. Med Clin Barc 2004; 122:767-72.
Ferri CP, Prince M, Brayne C. Global prevalence of dementia: a Delphi consensus study. Lancet 2005; 366: 2112-17.
Cullen B, O'Neil B, Evans JJ, et al. A review of screening test for cognitive impariment. J Neurol Neurosurg Psych 2007; 78: 790-9.
Erkinjuntti T, Kurz A, Gauthier S, et al. Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a radomised trial. Lancet 2002; 359: 1283-90.
O'Sullivan M. Leukoaraiosis. Pract Neuro/ 2008; 8:26-38.
Greenberg SM, Gurol ME, Rosand J, et al. Amyloid angiopathy-related vascular cognitive impairment. Stroke 2004; 35: 2616-19.
Khan U, Porteous L, Hassan A, et al. Risk factor profile of cerebral small vessel disease and its subtypes. J Neurol Neurosurg Psychiatry 2007;
: 702-6.
Hassan A, Hunt BJ, O'Sullivan M, et al. Homocysteine is a factor for cerebral small vessel disease, acting via endothelial dysfunction. Brain
; 127: 212-19.
Van Goor L, Woiski MD, Lagaay AM, et al: Review: cobalamin deficiency and mental impairment in elderly people. Age Aging 1995; 24:
-42.
Turner MR, Kevin Talbot. Functional vitamin B12 deficiency. Pract Neurol 2009; 9: 37-52.
Clarke R, Smith AD, Jobst KA, Refsum H, et al. Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol 1998; 55: 1449-55.
Quadri P, Fragiacomo C, Pezatti R, et al.: Homocysteine, folate and vitamin B12 in mild cognitive impairment, Alzheimer's disease and vascular dementia. Amer J Clin Nutrition 2004; 80: 114-22.
Wang H, Wahlin A, Basun H, et al. Vitamin B12 and folate in relation to the development of Alzheimer's disease. Neurology 2001 56: 1188-94.
Reynolds E. Folic acid, ageing, depression and dementia. Brit Med J 2000; 324: 1512-15.
Fassbender K, Mielke O, Bertsch T, et al: Homocysteine in cerebral macroangiography and microangiopathy. Lancet 1999; 353: 1586-7.
Hsu-Ko K, Farzaneh AS, Jen-Hau C, el al. The role of homocysteine in multisystem age-related problems: A systematic review. Journa/ of Gerontology 2005; 60A (9):1190-1201.
Vermeer SE, van Dijk EJ, Koudstaal PJ, et al. Homocysteine, silent brain infarcts, and white matter lesions: The Rotterdam Scan Study. Ann Neurol 2002; 51: 285-9.
Matsui T, Arai H, Yuzuriha T, et al. Elevated plasma homocysteine levels and risk of silent brain infarction in elderly people. Stroke 2001; 32:
-9.
Bertsch T, Mielke O, Holy S, et al. Homocysteine in cerebrovascular disease: an independent risk factor for subcortical vascular encephalopathy. Clin Chem Lab Med 2001; 39: 721-4.
Kruman II, Culmsee C, Chan SL, et al. Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity. J Neurosci 2000; 20: 6920-6.
McCaddon A, Davies G, Hudson P,et al. Total serum homocysteine in senile dementia of Alzheimer type. Int J Geriatr Psychiatry 1998; 13: 235-9.